Great.
Thanks, Johan.
I will add some numbers just to support the messages that Johan has given there. So overall, the group financial performance was very solid in the quarter. And pleasing for us to see good organic growth across the group. And I think one of the things that is most satisfying is that this growth is genuinely broad based across the regions, across the companies, across the countries, coming both from well-established businesses within the group, but also the recent M&A, driving both growth and margin improvement.
We look at some of the numbers. Johan mentioned them already. Net sales in Q1 up 13%. 5% of that organic.
With the FX headwind that we have been struggling a bit with in recent quarters. Adjusted EBITA up 21% in Q1, 8% of that organic. And also with the FX headwind affecting the EBITA side of things as well, but margin up to 9.8%, as Johan mentioned, continuing to move in the right direction.
If we go one level further down and look in a little bit more detail at the business areas, starting with Business Area North, performing well, with good organic growth across the region. Important to note that the large defence and preparedness sales that we have talked about during 2025 are now out of the comps, so it's good to see a clean quarter that shows how this region is doing without those comps confusing the picture. And we see adjusted EBITDA growth of 5%, with 4% of that organic, and net sales growth of 7%, with organic growth also at 7% in the quarter. A brief mention of the new Distribution Centre that we've talked about also in the past down in the southwest of Sweden, progressing nicely.
We're starting to do some tests in the facility which have delivered good results. And as a reminder, we will be ramping up that activity through the course of this year. There will be some additional double manning costs and some additional inventory coming in towards the end of 2026 and 2027. We will be fully operational in the early part of 2027 and the full personnel benefits coming through in the second half of 2027.
Business Area. West. Strong growth in the region. And pleasing to see that we are really getting some benefits from some of the scale effects in the region. So we see adjusted EBITDA growing 32%, of which 15% of that was organic. And we see net sales growing 12%, with organic growth contributing 5% to the net sales, quite a large negative FX effect in region West.
And the margin, as I mentioned before, moving nicely in the right direction up to 9.5% in the quarter. And, to reiterate the message for the group as a whole and all other regions, we see good organic growth from both established businesses and acquired units. With a particular note on Region West, where we see strong performance from our home care operations, which continue to find additional growth opportunities and are really starting to see some nice scale benefits from those operations, which is good to see. Turning to the third business area. Central.
Also strong sales and EBITDA growth across the region. Net sales up 26%, 13% organic, and Adjusted EBITDA up 47% in the quarter. Organic growth contributing on the net sales side, 3%.
And again, I repeat the message, but really a broad-based contribution to the growth across the companies, across the countries within the region.
And as we've talked about before, we continue to focus on margin enhancing activities in the region.
Just to look at the range, look at the portfolio, take out some of the less attractive products and segments from the range here.
Turning now briefly to our R/RK EBITA over net working capital. We talked about this many times. I always talk about it. It's a key internal metric for us, making sure that we're really focusing hard on our capital efficiency and capital utilization. And as we've also talked about many times before, an important source of the cash that we use to fund the M&A engine. So, good to see that that's still performing well across the group in the quarter.
The overall picture is really good, solid, robust cash flows. The overall picture is really good, with solid, robust cash flows. And hence that feeds into good visibility around our M&A planning as well. And hence, that feeds into good visibility around our M&A planning as well.
I'll say a few more words about that in a second. Cash flow from operating activities 419 million SEK in the quarter. Naturally driven by the strong top and bottom line that I've talked about on the previous pages, but also the continued work we do around working capital efficiency and squeezing cash out there. I should note that the 109 million that we saw in Q1 2025 was an abnormally low figure. We had numerous costs, if you remember, associated with the IPO and other related activities. So although cash flow is good and solid, and we're happy with 419, perhaps the growth is a little bit flattered by the low figure we had in the comparable period.
Regarding CAPEX, I briefly mentioned the Distribution Centre a few pages ago.
We have approximately 100 million SEK remaining to be paid out for that DC over the next 9 to 12 months, but as we've said, the development of that DC is progressing nicely. Looking ahead to future cash flows, particularly in Q2, we've had a few questions about this. I've discussed this with analysts and investors.
So just to be super transparent on this, we do have a relatively large earnout cash outflow coming in Q2 450 million SEK approximately.
So those, as a reminder, are for deals that were done, M&A deals that were done back in 2022 to some extent, 2023. Those businesses have developed well. They have reached the end of their earnout period at the end of 2025.
And then we pay the Earnouts after we've got the annual reports signed off and audited for those businesses, which is why we have the big cash outflow in Q2 450 million.
As I say, we have the dividend of 149 million SEK. Our first dividend, which will flow out during May. I want to emphasize that these non-regular cash outflows that we see coming up in Q2 are well modeled. They're well understood. They're fully built into our thinking, our leverage planning, our debt planning.
And of course that then leads into our capacity to do M&A.
And perhaps I also add a further note when you look forward to the Earnouts in 2027, i.e. For deals that we did in 2023 and to some extent 2024, whose earnout period comes to an end at the end of 2026, we expect that cash out amount to be around 130 million SEK. I think it's interesting just to contrast that with the relatively larger amount that we're going to be paying out now in Q2 2026. And I think that's an indication, not that those businesses have performed less well, but more that we have evolved our earnout model as we have gone forward through the development of our second engine. And then one final page from me just taking the cash flow and the leverage discussion one step further.
We have a stable leverage well below our target of 2.5, giving us good capacity for those continued acquisitions that are that key fundamental second engine. That's a part of our business. A few numbers on this page.
So I tried to take them steadily so we don't get confused. The Net Debt to EBITDA, according to our current definition and our current 2.5x target, comes in at 2.15 during the quarter. But for the two deals that we've completed in the quarter, Van Heek and GHC, we haven't yet fully paid out all of the cash for those acquisitions. The reason for that is we're actually waiting for the final annual reports, the audited annual reports. We like to receive that before we complete all of the cash outflow.
But clearly those are part of those deals. Those are cash amounts that are associated with completed deals. To be completely open, transparent, and clear, we've added those back.
And when that amount is added back, you see that actually 2.25 is the leverage in the quarter. And I think that's the more relevant figure to look at. And you can see on the right-hand side of this picture, the chart, our leverage is extremely stable.
We manage it in a good way and we're conscious to keep it at that stable level. I add one further footnote. Again, simply because I've discussed this so much with analysts and investors, there is an alternative way of looking at the leverage ratio. And actually, this way is equivalent to our bank's leverage covenant definition. And that would be to include all of the earn outs and outstanding payments for the next 12 months in the debt side of the calculation, but at the same time to also include the 12 month pro forma EBITDA from acquisitions that we've done, which I also think is very reasonable.
These are businesses that are now part of the Asker group, and their cash-generating capacity is part of the group. So it's only reasonable to include that as well. And if you were to use this alternative leverage calculation, you would come to a figure of 2.36. Just to reinforce again, that is not our current definition, but it's another way of looking at it.
And I think what it does when you see that is it just reinforces the point that the strong and stable cash flows that this business generates enable us to manage leverage, have good insight, and deliver on our M&A agenda going forwards.
With that, I pass back to Johan.